期刊
XENOTRANSPLANTATION
卷 22, 期 4, 页码 302-309出版社
WILEY
DOI: 10.1111/xen.12174
关键词
anti-IL-6R antagonist; costimulation blockade; genetically engineered; kidney; pig; xenotransplantation
资金
- NIH [U19 AI090959, U01 AI068642, R21 A1074844, RR012317-09]
- University of Pittsburgh
- Revivicor, Inc., Blacksburg, VA
- NHP Reagent Resource [HHSN272200 900037C]
The longest survival of a non-human primate with a life-supporting kidney graft to date has been 90days, although graft survival >30days has been unusual. A baboon received a kidney graft from an -1,3-galactosyltransferase gene-knockout pig transgenic for two human complement-regulatory proteins and three human coagulation-regulatory proteins (although only one was expressed in the kidney). Immunosuppressive therapy was with ATG+anti-CD20mAb (induction) and anti-CD40mAb+rapamycin+corticosteroids (maintenance). Anti-TNF- and anti-IL-6R were administered. The baboon survived 136days with a generally stable serum creatinine (0.6 to 1.6mg/dl) until termination. No features of a consumptive coagulopathy (e.g., thrombocytopenia, decreased fibrinogen) or of a protein-losing nephropathy were observed. There was no evidence of an elicited anti-pig antibody response. Death was from septic shock (Myroides spp). Histology of a biopsy on day 103 was normal, but by day 136, the kidney showed features of glomerular enlargement, thrombi, and mesangial expansion. The combination of (i) a graft from a specific genetically engineered pig, (ii) an effective immunosuppressive regimen, and (iii) anti-inflammatory agents prevented immune injury and a protein-losing nephropathy, and delayed coagulation dysfunction. This outcome encourages us that clinical renal xenotransplantation may become a reality.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据